Track topics on Twitter Track topics that are important to you
Announces commercial oligonucleotide API manufacturing expansion in CordenPharma Colorado
CordenPharma has expanded its oligonucleotide active pharmaceutical ingredient manufacturing capacity in Colorado, US.
The expansion, which was completed in Q1 2018, will make the Colorado, US site one of the largest oligonucleotide manufacturing sites worldwide
We have published hundreds of CordenPharma news stories on BioPortfolio along with dozens of CordenPharma Clinical Trials and PubMed Articles about CordenPharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CordenPharma Companies in our database. You can also find out about relevant CordenPharma Drugs and Medications on this site too.